Search results

The Graduate Institute is part of ANSTO’s Innovation Precinct and links all graduates together to create a network of Australia’s brightest young minds focused on the future.

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.

Using geoarchaeology to reconstruct the history of an ancient Khmer city.

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.

The Government is safeguarding Australia’s sovereign capability to produce vital nuclear medicines by launching a $30 million project to design a new world-leading manufacturing facility to be built at Lucas Heights in Sydney.

ANSTO has made a contribution to the successful NASA/JPL Ingenuity helicopter flight on Mars through instrument scientist, Dr Andrew Nelson, who was one of the many developers of the open-source software SciPy used in the flight.

Explore ANSTO's range of publications and reports available for the public.

Neutron Capture Enhanced Particle Therapy developed at ANSTO.

New screening method developed to confirm if deuteration improves metabolic stability.

Hear from our most recent addition to the nandin Innovation Centre, Tomonori Hu, Founder and CEO of Miriad.

ANSTO-nandin innovation hub win global hackathon challenge from NASA with COVID19 solution.

Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape

ANSTO will participate in a New Zealand Marsden project which will search for chemical clues linked to the origins of life on Titan, Saturn’s largest moon. 

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

ANSTO scientist, Dr Klaus Wilcken of the Centre for Accelerator Science, used cosmogenic nuclide dating to determine the ages of layered sand and gravel samples, in which seven footprints of the flightless bird, the moa, were found on the South Island in New Zealand in 2019.